缺血性卒中患者白细胞计数的全基因组关联研究
本研究纳入发病24小时内具有白细胞计数数据的缺血性卒中患者,开展全基因组关联研究和基因表达研究。发现研究(n=2064)与复制研究(n=407)共同揭示了一个与白细胞计数相关的新位点14q24.3,联合分析(n=2471)后另有5个多态性达到全基因组显著性(P<5×10-8)。14q24.3位点与急性卒中结局相关(rs112809786,P=0.036),并与ACOT1和PTGR2基因表达相关。
要点
- 发现缺血性卒中急性期白细胞计数的首个遗传位点14q24.3。
- 该位点同时与急性卒中结局相关(rs112809786,P=0.036)。
- 一般人群中的白细胞计数相关多态性在卒中急性期未显示显著性。
核心结论
- 发现了首个与缺血性卒中患者白细胞计数相关的遗传位点14q24.3,该位点也与急性卒中结局相关。
- 卒中急性期的免疫细胞调控可能与健康状态不同。
研究设计与样本
- 研究纳入发病24小时内具有白细胞计数数据的缺血性卒中患者,进行全基因组关联研究和基因表达研究。
- 全基因组关联研究包括发现队列2064例和复制队列407例,联合分析共2471例。
主要发现
- 全基因组关联研究揭示了一个与白细胞计数相关的新位点14q24.3。
- 联合分析(n=2471)后,另有5个多态性达到全基因组显著性(P<5×10-8)。
- 14q24.3位点与急性卒中结局相关(rs112809786,P=0.036),并与ACOT1和PTGR2基因表达相关。
- 既往在一般人群中与白细胞计数相关的多态性在本研究中未显示显著性。
关键数值与推荐
- 全基因组显著性阈值定义为P<5×10-8。
- 14q24.3位点与急性卒中结局的关联P=0.036(rs112809786)。
临床怎么用
- 急性期白细胞计数相关遗传位点可能有助于识别卒中结局风险,但尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Immune cells play a key role in the first 24h poststroke (acute phase), being associated with stroke outcome. We aimed to find genetic risk factors associated with leukocyte counts during the acute phase of stroke. Methods- Ischemic stroke patients with leukocyte counts data during the first 24h were included. Genome-wide association study and gene expression studies were performed. Results- Our genome-wide association study, which included 2064 (Discovery) and 407 (Replication) patients, revealed a new locus (14q24.3) associated with leukocyte counts. After Joint analysis (n=2471) 5 more polymorphisms reached genome-wide significance (P<5×10-8). The 14q24.3 locus was associated with acute stroke outcome (rs112809786, P=0.036) and with ACOT1 and PTGR2 gene expression. Previous polymorphisms associated with leukocyte counts in general-population did not show any significance in our study. Conclusions- We have found the first locus associated with leukocyte counts in ischemic stroke, also associated with acute outcome. Genetic analysis of acute endophenotypes could be useful to find the genetic factors associated with stroke outcome. Our findings suggested a different modulation of immune cells in stroke compared with healthy conditions.
引用
- Torres-Aguila NP, Carrera C, Giese AK, et al. Genome-Wide Association Study of White Blood Cell Counts in Patients With Ischemic Stroke. Stroke. 2019. PMID: 31587654. doi:10.1161/STROKEAHA.119.026593
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。